ARS Pharmaceuticals, Inc. SPRY Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from ARS Pharmaceuticals, Inc.’s reported figures.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s invested capital?
- ARS Pharmaceuticals, Inc. (SPRY) reported invested capital of $133.51M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s invested capital changed year-over-year?
- ARS Pharmaceuticals, Inc.'s invested capital decreased by 29.4% year-over-year, from $189.18M to $133.51M.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s invested capital?
- Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s invested capital has grown at a -15.7% compound annual growth rate (CAGR), from -$397.75M to $169.32M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).